companies that make glp-1 drugs from the Gray Market Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists
Description
Ultimately, 70 articles were cited based on relevance, methodological quality, and lack of redundancy, ensuring a robust and focused evidence base for this review
Liraglutide and obesity: a review of the data so Far
It should be noted that this study was funded by Novo Nordisk, the pharmaceutical company that produces semaglutide
Potts JE, Gray LJ, Brady EM, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Yasuda T, Harada N, Hatoko T, Ichimura A, Ikeguchi-Ogura E, et al
van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG
